Heparin-induced thrombocytopenia successfully treated with fondaparinux.
We report the successful treatment of a patient with HIT-associated venous thrombosis by fondaparinux, a synthetic pentasaccharide. Although not yet approved for this indication, this new anticoagulant may be a useful alternative in the setting of HIT.
Service de Médecine Interne Générale, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
S
S
Seldrum
M
M
Lambert
Ph
P
Hainaut
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D005170:Factor X; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D005500:Follow-Up Studies; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D005170:Factor X; D006493:Heparin; D000077425:Fondaparinux